Salto Partners

  • Home
  • About
  • Services
    • Strategy
    • Execution
    • Compliance
  • Verticals
    • Life Sciences
    • Genomics
    • Private Equity
  • Insights
    • ISO 13485
    • IVDR
    • Perspectives
      • National Genome Programs
      • Pharmacogenomics at Scale
      • Long-Read Sequencing
      • AI in Clinical Genomics
  • News
  • Contact
Salto Partners · Strategy. Execution. Compliance.

Grow faster. Execute better. Stay compliant.

Hands-on leadership for life sciences, genomics and private equity portfolios, from someone who has run the business himself.

Let’s talkWays to work together
Andreas Scherer, PhD · Founder & CEO

Strategy

Executives in a strategy meeting

We design the go-to-market that drives growth: sales strategy and process, partner models, and the distribution channels that fit your markets.

Execution

Business team in an active discussion

We turn strategy into results with AI-enabled processes, clear accountability and lean operations, working alongside your team until it sticks.

Compliance

Executive reviewing a document with a colleague

We guide medical device and diagnostics companies through ISO 13485 and IVDR, so regulation supports growth instead of slowing it down.

Have a growth or compliance question on your desk?

Let’s talkConnect on LinkedIn

Life Sciences

Scientists reviewing results together

We help diagnostics, medical device and biotech companies bring products to market with the right channels, partners and quality systems.

Genomics

Researchers reviewing data on screen

We help genomics software, sequencing and testing companies move from research into clinical markets and build channels into labs worldwide.

Private Equity

Executives shaking hands to close a deal

We work with investors and management teams to build the commercial engine that drives portfolio value from acquisition to exit.

© 2026 Salto Partners Inc. · Strategy. Execution. Compliance.